The re is a growing dema nd in clini cal c he mi stry for ana lyses to be pe rformed in a manner aUowing compari sons of res ults among laboratories and, from time to tim e, in th e same laboratory. Reliable comparability requires adequate procedures of standardization for s pectrophotome tri c and Huorometri c instrum e nts and me thod s. Proble ms with che mi cal and instrume ntal standardization are di sc ussed.
I. Introduction
Spectrophotometric analyses in the routine clinical chemistry laboratory are performed within a unique framework. This framework imposes conditions responsible for many of the problems of inaccuracy and lack of standardization in clinical chemistry. The factors comprising this framework include: a. Workload-many clinical chemistry laboratories are performing in excess of a quarter of a million analyses each year, and this number has been growing in the United States at a rate as high as 15 percent per annum.
b. Time-to enable prompt action by a physician, results are nearly always required on the day the specimen is collected; quite often results are needed within an hour. A twenty-four hour service must usually be maintained.
c. Range of analyses -as many as 40 different determinations are commonly available on request with a wide range of "special investigations" available by arrangement.
d. Type of sample -analyses are most commonly performed on serum or plasma, a viscous, proteinrich complex matrix available in restricted quantity.
e. Cost -clinical chemistry determinations contribute to the rising costs of health care; therefore the laboratory director must be cost-conscious, though not at the expense of precision and accuracy.
f. Personnel-the competent clinical chemistry technician must master a growing number of techniques, and operate a wide range of instrumentation that depends on many different principles.
As long ago as 1947, Belk and Sunderman [1] 1 s uggested the need for standardization in the clinical chemistry laboratory. They distributed aqueous solutions of glucose , chloride, urea and calcium, serum for measurements of total protein and albumin, and citrated whole blood for measurements of hemoglobin concentration, to a number of laboratories in Pennsylvania. They revealed wide discrepancies between results from different laboratories analyzing identical specimens. For example, 27 of 41 laboratories obtained urea nitrogen results more than 5 mg/IOO ml from the actual concentration of 45 mg/lOO ml. That poor accuracy of results was a worldwide problem was demonstrated by similar reports from Australia [2] , Britain [3] , Canada [4] , and New Zealand [5] .
A major change in the operation of most routine clinical chemistry laboratories during the last 15 years has resulted from the introduction of mechanized and automated analytical equipment, both of the dis· crete sample and continuous flow type. That the introduction of such equipment can improve day-today precision of laboratory results has been demonstrated by Mitchell [6] . Gowenlock [7] , reporting on an interlaboratory trial in Britain in 1965, concluded that apart from potassium determinations in serum, laboratories using AutoAnalyzer 2 (Technicon Instruments Corporation, Tarrytown, N.Y.) methods produced more consistent results. Many laboratories now have quality control schemes usually checking the precision of results either by using pooled human sera, commercial control sera or, in the United States, by participating in the College of American Pathologists' Quality Assurance Service.
It might be assumed that the introduction of mechanized and automated equipment, together with the use of quality control techniques, would by now have improved accuracy and thus inte rlaboratory agreement. The results of the latest surveys are not always reported in a comparable way to those of Belk and Sunderman [1] , making such judgment diffic ult. For example, the College of American Pathologists' Quality Evaluation Program for 1971 divided the results for a given determination into groups according to the type of analytical method used; no overall range, or range for results within a group, was given. The results of the national quality control scheme in Britain, however, give the individual results obtained by each laboratory. Figure 1 (taken from the British scheme for a week in September 1969) shows the wide distribution of results from different laboratories when aliquots of identical serum specimens were analyzed for uric acid.
Even if there has been a slight improvement in the accuracy of results since 1947, the performance of clinical chemistry laboratories still falls far below that which should be expected.
A precise analytical method is not necessarily accurate and herein probably lies a major cause of the problem. Lack of accuracy in spectrophotometric methods of analysis may be caused by several factors including lack of suitable standards, inadequate colorimeters and spectrophotometers; and poor specificity of the chemical reaction. The latter factor is outside the scope of this discussion. Though there is frequently an interdependence between the chemical and instrumental aspects of analysis, we will consider them separately.
! in order to adequa~ely describe materials and experimental procedures·~ it was occa· sionally necessary to identify comm ercial products by manufacturer's name or label. In no instances does s uc h identification imply endorsement by the National Bureau of Standards, nor does it imply that the particular product or equipm ent is necessarily the best available for that purpose.
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II. Instrumental Considerations
To function appropriately within the described framework of clinical chemistry requirements, a spectrophotometric analytical system must satisfy certain criteria. Those criteria concerned with economics, i.e., initial cost, operating cost and analytical rate, will, for the purpose of this discussion, be considered satisfied; only those criteria directly affecting standardization will be considered. Generally, these criteria are: Satisfaction of the criterion of adequate specification implies a thorough knowledge of the measurement characteristics of the instrumental system and of the interaction of those characteristics with those of the chemical system. It is essential to know: the range of absorbance which the spectrophotometric device will be required to measure, the wavelength at which measurements must be made, spectral band widths of absorption spectra to be investigated, temperature characteristics of both instrumental and chemical systems, and calibration stability of the instrumental system.
Once the necessary c haracteristics of the instrument sys tem have been defined, performance must be verified. An adequate evaluation of instrument performance requires reference materials of inde· pendently verifie d quality. These materials may be used to check wavelength accuracy, spectrophoto· metric linearity and, if necessary , spectrophotometric acc uracy.
A. Wavelength
Several wavelength tests are available. In instruments where its use is convenient, Rand [8] recommended the mercury vapor lamp as a calibration source because of its many well defin ed emission lines. Where use of a mercury vapor lamp is inconvenient because of mechanical considerations, the sharp absorption bands of didymium and holmium oxide glass filters [8, 9] can furnish useful calibration points. These same filters, however, must not be used for spectrophotometric linearity and accuracy tests. Their narrow absorption band widths, whi ch suit them for wavelength testing, make their transmi ssion much too sensitive to wavelength settin g accuracy.
B. Spectrophotometric Linearity
Reule [10] pointed out that spectrophotometric line arity is a necessary, but not a s ufficient, condition ' for spectrophotometric accuracy. ' He noted that scale readings could be linear with light absorbance change but differ from true absorbance by a non unity factor. On thi s basis, he objected to the use of absorbing materials to test s pectrophotometer performance; and he suggested a precise test method using carefully controlled additions of light. Reule's meth od is not suitable for general clinical laboratory use because of its complexity. However, the information he presents is fundamental to understanding of linearity and accuracy tests.
Only spectrophotometric linearity is required in many clinical chemistry assays. In these cases, Reule's objection to tests based on s ubstances which obey the Lambert-Beer law is negated and stable solutions of substances with broad absorption bands near the wavelengths of interest may be employed. Acidic solutions of cobalt ammonium sulfate and alkaline solutions of potassium chromate [ll] have been suggested by NBS. Rand [8] favore d acidic potassium dichromate (available from NBS as Standard Reference Material 136c). Buffered solutions of reduced nicotinamide adenine dinucleotide (NADH) may be useful if their marginal stability is taken into account. Solutions carefully prepared from materials of known ancestry can serve as useful spectrophotometric linearity benchmarks in both wide and narrow bandwidth s pectrophotometers.
An instrumental characteristic which can markedly reduce the linear range of a photometric device is stray light [12] . Results of an experiment in our
laboratory illustrate the effect of stray light and are shown in figure 2. These data were obtained on an AMINCO Rotoche m (American Instrum ent Company, Silver Spring, Md.) from determinations of the transmittance of solutions of NADH in 0.1 mol·1 -1 phosphate buffer (pH = 7.4). Measure me nts were take n at 340 nm , both with and without a minus-visible 360 nm cutoff filter in the photo detector window. The fall-off of linearity see n at low tran smittance without th e filt er results from stray heterochromati c light "sneaking past" the monochromating element and into the photo detector without being attenuated by the absorption bands of the sample. The filter recommended by the manufacturer in this example is typical of the "stray light" and "order-sorter" filters found on prism and grating monochromators. Mis-or disuse of such filters can degrade the performance of even the best spectrophotometer to a level far below the specifications upon whi ch its procurement was based.
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C. Spectrophotometric Accuracy
When the goal of instrument testing is verification of spectrophotometric accuracy, several pitfalls appear beyond those associated with linearity. Even though linearity tests may be satisfied in characterizing the spectrophotometric performance of wide bandwidth devi ces, in most cases these in struments are not capable of s pectrophotometric accuracy. The data in figure 3 were obtained in our laboratory from solutions of buffered p-nitrophenol measured at 404 nm in an AMINCO Rotochem. The curves show that increasing spectral bandwidth causes apparent absorbance decreases from the "true" absorbance measured on the Beckman DU (Beckman Instruments Inc., Fullerton, Calif.) at 0.6 nm bandwidth; linearity remains good. If the instrument under test is of adequately narrow Q) bandwidth to warrant investigations involving spectrophotometric accuracy, then the materials used to 'assess this must be considered. In obtaining th-e NADH results described in figure 2, we noticed that the measured absorbances were lower than predicted from weight concentration and the accepted molar absorptivity of NADH reported by Horecker and
Kornberg [131-Solutions of NADH (Sigma > 98% purity) from two lot numbers were prepared in phosphate buffer, and their absorbances measured at 340 nm on a Beckman DU spectrophotometer. Our calculated molar absorptivities were approximately two-thirds of the expected value. When the indirect determination based on enzymatic conversion of nicotinamide adenine dinucleotide (NAD) to NADH described in [13] was duplicated, molar absorptivities in good agreement with the reference value were obtained. The source of this discrepancy has not yet been resolved, but it is obvious that direct use of NADH as a spectrophotometric accuracy-test material must be approached with caution. Slavin [14] discussed the relative merits of liquid and solid test materials for spectrophotometric accuracy assessment and concluded that the requirements of convenience and stability favored use of solid materials. He described applications of the Chance-Pilkington (England) ON-I0 neutral filter glass and of perforated metal screen filters. Copeland, King and Willis [15] described the use of the NBS carbon yellow filter glass as absorbance standard for the 540 nm assay of cyanmethemoglobin but lamented the strong wavelength dependence (0_0083 A/nm) of the filter at the desired wavelength.
Wavelength dependence is a criticism common to most reference materials proposed for use in spectrophotometric accuracy tests, especially when such tests are conducted in the environment of the clinical chemistry laboratory. Each material requires considerable discretion in choice of wavelength range for which it is used_ If the material is used where its absorbance is strongly wavelength-dependent, then seemingly trivial errors in wavelength calibration can lead to decidedly nontrivial errors in spectrophotometric accuracy assessments_ Since the Beckman DU used by Copeland, King, and Willis [15] has a wavelength accuracy of about ± 0_4 nm, this measurement on the NBS carbon yellow filter could have been in error by 0.0035 A units from wavelength inaccuracy alone.
D. Functional Considerations
Problems resulting from inadequate wavelength accuracy, spectrophotometric linearity and spectrophotometric accuracy may be minimized by using extreme care in specifying and verifying a spectrophotometric system, but we ask what are the implications of poor performance of these functions in the nonideal world of the clinical chemistry laboratory.
In enzyme assay by kinetic measurements, the rate of substrate conversion is calculated from molar absorptivity and absorbance change with time. When substrates and conversion products have relatively narrow spectral bandwidth absorption curves, accurate calculation of the concentration from absorbance and molar absorptivity will depend on accuracy of wavelength setting. To illustrate the effect of wavelength dependence, we performed assays of serum alkaline phosphatase using conversion of p-nitrophenyl phosphate to p-nitrophenol. Measurements of kinetic rates were made at the correct wavelength of 404 nm and at "erroneous" wavelengths of 414 nm and 424 nm. The results in table 1 show that the apparent activities are considerably lowered by errors in wavelength. Even in the assays in which comparison measurements are made between standard and unknown samples, spectrophotometric linearity is required, except in the trivial case where the standard and the unknown have exactly the same light transmittance. With instruments of nominally acceptable linearity, there is still danger that unknown samples may be encountered with transmittal"'ce outside the verified range of linearity, and routine treatment of such samples will cause reduction in precision of the measurement. This loss of precision stems from either
Necessity for ve rification oflin earity for eac h individual in strum e nt is obvious becau se so me commonly used cJjnic al colorime ters hav e signifi cant de viations from lin earity at abs orban ces as low as 0.5 (Associati on of CJjni cal Bioche mists' (A.c.B.) reports [16 , 17] ).
Another seri ous , but less appare nt , so urce of precision loss res ults from measurin g at tran s mittances far removed from 0.368 (Absorbance = 0.434). Near this tran s mittance Beer's law calculation s yi eld the lowest relativ e conce ntration e rror (IlC/C) for any give n uncertainty in tran s mission meas ure ment [18, 19] . Willard , Merritt and De an [20] show the relative conce ntrati on e rror, res ultin g from a tran s mittan ce meas ure me nt un certainty of 0.4 pe rcent, to range from 8.2 percent at 0.95 T through 1.1 percent at 0.40 T to 8.7 percent at 0.01 T.
The assay of e nzym es by kine ti c rate dete rmin a tion ofte n requires me as ure me nt of s mall c han ges in absorban ce. Many s pectrophotome ters co mmonly use d for direct con centration assay do not have absorban ce resoluti on adequate to meas ure these s mall differe nces precisely. Absorbance is proportional to concentration of the absorbin g s pec ies in direct me asure me nts. Th e refore , for a give n relative e rror in absorbance meas ure me nt , th e relativ e error in concentration is the same; e.g., if an absorban ce meas ure me nt is 0.500 ± 0.002, th e n the relative error is ± (100 pe rcent X 0.002/0.500) or ± 0.4 percent, and the relative error in conce ntrati on calculated from this absorbance meas ure me nt al so will be ± 0.4 percent.
Howe ve r , if the same spectrophotome tri c e rror (± 0.(02) is present in an in strume nt used to mea sure a kine ti c rate, the relative error on th e assay res ults may be muc h worse. When th e e nzyme as partate amin otran sferase (S GOT) is dete rmin ed by a co mm on kin e ti c rate me thod [21] , th e absorbance c hange observed for sam pIes from normal subjects is of the order of 0.01 pe r min at 30°C. Typical absorban ces for two readings take n 2 min apart are 1.000 and 0.980 and the differe nce , 0.02. In the wors t case, wh en the meas urement errors for eac h of the two readings are additive , the relative e rror could be ± (100 percent X 0.004/ 0.020) = ± 20 perce nt. The fundam e ntal proble m is that of measuring precisely s mall differe nces in large numbers. Thus , small relative errors in each of the two meas urements can lead to large relative errors in the value derived from their diffe re nce.
This fundamental problem of precisely measurin g small differences is furth er aggravated by th e wides pread use of in strume nts with digital di splay or printout of readings. While digital di splays do muc h to reduce likelihood of operator re adin g error , the y conceal the fa ct that precision of absorbance measurement is more diffic ult to obtain at low transmittan ces. It is appare nt on a me te r scale, Jjn ear for percent trans mi ssion, that the ran ge of 1.0 to 2.0 absorban ce occupies only 9 pe rce nt of the entire tran smi ssion scale; he nce a technician may be leery of makin g readings in thi s range. But if a digitial di s play s hows 1.931 for one absorbance re ading and 1.968 for anothe r, th e operator is likely to interpret those readin gs as exact wh e n, in fact, th e y are very proba bl y quite inaccurate.
If an analog (continuously variable) signal is to be di s played di gi tally , an analog·to·digital conversion mu st occur. The accuracy with whi c h the numbe r displayed re prese nts the original analog si gnal depends on the sophisitication of conversion circ uitry; that accurac y is not ab solute and can be quite poor.
As an example , we calculated the a bsorbance resolu· tion of Ge ne ral Medical Sc ie nces -Atomi c Ene rgy Commission (GeMSAEC) s pectrophotome tri c sys te ms. These syste ms employ analog-to-digital conversion circ uitry with resolutions of 1/2 10 = 0.1 percent (te n bit) or 1/21 2 = 1 in 0.025 percent (12 bit) . Th e best absorban ce resolution deliverable by these two converters at seve ral ab sorbance levels is shown in table 2. The differe nce in resolution be tween the two converters is appare nt. 
E. Routine Instrument Performance Verification
Although the necessity for initial ve rifi cation of instrume nt pe rformance is unde niable, re latively little has been don e to in corporate separate in strume nt checks into th e clinical laboratory quality control program. For example, this omission may permit an undetected malfun ction to re duce th e linear range of the s pectrophotom eter. Samples of normal con ce ntration could s till give acc urate readings, but abnormally high conce ntration samples would produ ce re adings falling outside the range of the instrument's Jjn ear res pon se. To be s ure , use of control samples simulating abnormal ass ay values would reveal thi s fault , but at the expense of complete re-run of all samples ass ayed precedin g di scove ry of the diffic ulty.
Se veral wavelength and abs orbance ve rification de vi ces are available in readily us able form. Examples are th e conve ni ent Gilford (Gilford Instrum e nt Laboratories , Oberlin , Ohio) calibration device for their 300-N Mi crosample Spectrophotome te r, and the Arthur H. Thomas (Arthur H. Thomas Company, Philadelphia, Pa. ) didymium and holmium oxide filter glasses supplied with an adapte r to fit into any sample carrier designed to hold standard 1 em square cuvettes. Howe ver , it must be emphasized that it is appropriate use, and not mere possession of verification devices such as these, which standardize laboratory performance .
F. Operator Considerations
Even an instrument system which is capable of meeting all necessary specifications will not reliably perform accurate analyses if that system is not designed to be easily operated in the proper manner. However, it is difficult to visualize a more ergonomically efficient spectrophotometer than the Gilford 3QO---N_ We have seen this instrument used to measure absorbances greater than 3_0; used to measure absorbance at two wavelengths without readjusting the zero setting; calibrated with the zero-set control and even operated from a cold start with no adjustment checks; all by experienced and presumably welltrained technicians who should know better. An undetermined but undoubtedly large contribution to poor quality control arises from improper operation of laboratory equipment, due to poor instrument design and poor operator understanding_ Radin, in 1967, [22] , reviewed the definition and use of standards and the standard materials available to the clinical chemist, and discussed the limitations of various so-called standards_ His view that "there is actually very little in the way of official definitions of standards for the clinical chemist" was reinforced by a joint report of the National Academy of Sciences , National Research Council Subcommittee on Reference Materials r23J-The situation has improved since that time, as evidenced by the reports of Young and Mears [24] , Meinke [25] , and Zief and Michelotti [261-The improvement has been due to the introduction by the National Bureau of Standards of Standard Reference Materials (SRM) for use in clinical chemistry. To July, 1971, these include cholesterol, urea , uric acid, creatinine, calcium carbonate, bilirubin, D-glucose, potassium chloride, tris (hydroxymethyl) aminomethane, tris (hydroxymethyl) aminomethane hydrochloride and glass filters for spectrophotometry_
III. Chemical Standardization
The importance of the SRM's must not be underestimated; however, they represent a solution to only part of the problem_ The clinical laboratory worker must be aware of errors which may occur despite the availability of SRM's; stability of standard solutions is particularly importanL The variable stability of solutions of uric acid is well known, while Gowenlock [7] showed that in part, the lack of interlaboratory agreement for the determination of serum urea could be attributed to deterioration of aqueous urea standards containing no preservative_ In a few cases, SRM's when used in aqueous solution are not ideal standards in clinical chemistry. Recently, we were investigating the determination of uric acid by an adaptation of the supposedly specific uricase neocuproine method [27] , both manually and on the Beckman DSA-560_ Unable to get 100 percent recovery of uric acid added to pooled human serum, we discovered that the slope of the standard uri"C acid curve (using SRM) can be varied according to the amount of bovine albumin added. When the concentration of bovine albumin is approximately 7.0 gfl00 ml, 100 percent recovery of added uric acid is attainable.
A large number of routine clinical chemistry laboratories are using multichannel analyzers of both continuous flow and discrete sample type_ Aqueous standard solutions containing a mixture of known amounts of all the substances commonly being determined in the routine clinical chemistry laboratory are not available_ Multichannel machines are therefore being calibrated with commercially supplied calibration sera for which values for each determination have been assigned by the manufacturers_ That wide differences may occur between the values obtained on the same machine with sera from different manufacturers, and even between lots from the same manufacturer, has been reported by Childress [28] and Helman, Reingold and Gleason [29] _ These differences may occur for a variety of reasons, e_g_, variation in weight or homogeneity of materiaL The Scientific and Technical Committee of the Association of Clinical Biochemists (A.C.S.) [30] reported variation in dry content from vials (all of the same lot number) of some manufacturer's control sera to be as high as 13_80 percent C.V_ Six of the 10 brands investigated had coefficients of variation of over 2_0 percent. The deviation of the weight of the contents of these vials could be correlated to the deviation in analytical results obtained when these vials were reconstituted_ Data from our laboratory (table 3) shows the percentage deviation from the mean dry weight content of 10 vials of control sera compared with the percentage deviation from the mean analytical value for several determinations performed on the contents of each viaL The 10 vials were selected at random from a box of 40 vials (all of the same lot number); great care was taken to assure the correct amount of water was added to each viaL Replicate aliquots from each vial were analyzed in the same run. Excellent agreement was obtained between replicate analyses from the same vial for all the determinations_ The variation in dry 'weight content of the vials is unacceptable, however. If the contents of each vial is representative of a homogeneous batch , one would expect the deviations from the mean assay values to be the same as the deviations of the weight values; this is not the case. Most batches of control sera from manufacturers are not subject to the large errors shown here. The large errors, however, pose the question of how frequently smaller and less easily recognized errors occur. The results showing variability of vial content were obtained on what was described by the manufacturer as control serum, not calibration serum. However, the same manufacturing standards are required for both control and calibration purposes.
Amador, Massod, and Franey [31] compared the values they obtained for aspartate aminotransferase in three commercial control sera with the values assigned by the manufacturer and found differences of 11 to 17 percent (possibly due to the manufacturer failing to provide sufficient details of the method they used to assign the values)_ In a more recent paper, Dobrow and Amador [32] reported a similar study for lactate dehydrogenase, aspartate aminotran sferase, alkalne and acid phosphatase, and amylase. They concluded that the activities stated by six of the eight manufacturers were doubtful or unacce ptable in more than 50 percent of the sera tested. Bowers, Kelley and McComb [33] have shown that in some assay procedures, animal alkaln e phos phatases (ofte n used in commerc ial control sera) do not be have identically to human serum alkaline phosphatase. Thes e findings clearly indi cate that c urre ntly available calbration sera should not be used directly as calibration mate rials for any analytical procedure.
Cali [34] s ugges ted recently that SRM 's make verification of comme rcial calibrati on se ra possible; this stateme nt is correct only if referee me thods of analysis are available for use in conjunction with th e S RM' s. NBS will publs h th e first referee me thod for th e determination of calcium s hortly. The availabilty of referee methods and SRM's will do muc h to improve standardization in large laboratories. However , in small laboratories, where the proble m is greatest, shortage of manpower a nd eq uipm e nt does not permit analysi s of calibration sera by referee me thods. W e suggest that NBS consider the production of refere nce sera with values for the common routine de terminations a ssigned through use of their own SRM's and referee methods. These NBS reference sera would be used by laboratories to check co mmercial sera used for daily calibration of multichannel analyzer s.
An alternative to the production of reference sera by NBS may be a certification program for commer cial products. An example of the way in whic h an independent laboratory can be used for standard and reagent certification has been de monstrated by the c yanmethemoglobin certification program of the College of American Pathologists, as d escribed by King and Willis [35] .
In the meantime, the situation could be improved if the manufacturers used greater c are in the preparation of calbration sera. When assigning values to calibration sera, they should indicate the exact methods used for this purpose. Values for aspartate aminotransferase and alkaline phosphatase, for example, are frequently said to hav e been assigned usin g the Karme n [36] or Bessey, Lowry, and Broc k [37] methods, respectively. Almost certainly , modifi cation s of these me thods (with regard to s ubstrate co nce ntration buffer type, e tc.) have been used, res ultin g in quite different activities from the original me thods.
IV. Conclusions
1. Spectrophotometric analyses in the routine clini c al c he mi stry laboratory are performed within a unique fram ework.
2. The accuracy of res ults in clinical chemistry laboratories falls far below the level that should be expected.
3. Choice of instrumentation must be based on a thorough understanding of both the c h aracteri s tics of the instrume nt and the assays whi c h must be perform ed.
4. Exce pt in the case of inadequate absorbance resolution, instrument availability does not gene rally limit clnicallaboratory performance.
5. Mate rials for verification of in strume nt performance are often not available in a form s uitable for routine use in the clinical laboratory.
6. Referee analytical methods are need ed for use in conjun ction with NBS standard ref erence materials.
7. The only materials c urrently available for calibration of multichannel analyzers are comme rcially prepared sera. Because of ill-defined me thods of assigning values and poorly understood properties of enzymes from non-human sources, unve rifi ed use of th ese materials for calibration is highly undesirable.
8. The situation with regard to calbration sera could be impro ved by:
a. Greater care in the manufacture of calibration sera and provision of information concerning the exact method used to assign values to the material.
b. Certification of commercial calibration sera by an inde pendent laboratory using NBS standard reference materials and referee methods.
c. Preparation by NBS of reference sera, to which values are assigned using standard reference materials and referee methods. Such reference sera could be used by laboratories to assign values to new batches of commercial sera.
9. The most sophisticated and versatile spectro· photometric system can yield standard res~lts only when operated within its limitations. ChemIcal and serum reference materials must be used with due reo gard for their limitations. It is axiomatic then that, to understand and fully control what he can do, the labora· tory operator must also understand what he cannot do with analytical apparatus and methods. He must be able to recognize bad results as bad and be able to interpret these mishaps to correctly evaluate labora· tory performance just as the physician should interpret good laboratory results in diagnosis of the patient's physiologic performance.
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